Related Experiment Video
Updated: May 31, 2026

11:34
A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Fighting against viral hepatitis: lessons from Taiwan
1Department of Internal Medicine, National Taiwan University College of Medicine, Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan. chends@ntu.edu.tw
Hepatology (Baltimore, Md.)
|July 2, 2011
Summary
Taiwan
Area of Science:
- Hepatology
- Public Health
- Virology
Background:
- Viral hepatitis and its complications pose significant global health challenges.
- Taiwan has made substantial progress in controlling viral hepatitis sequelae over four decades.
- The author played a pivotal role in Taiwan's hepatitis control initiatives.
Purpose of the Study:
- To provide a perspective on the historical development and success of Taiwan's Viral Hepatitis Control Program.
- To highlight key research contributions and clinical advancements in managing viral hepatitis and its sequelae.
- To discuss future challenges and predict liver disease patterns in Taiwan.
Main Methods:
- Retrospective review of public health initiatives and research endeavors in Taiwan.
- Description of the establishment and monitoring of the Viral Hepatitis Control Program.
- Discussion of pioneering treatment strategies for chronic hepatitis C and risk factor analysis for hepatitis B.
Main Results:
- Significant reduction in hepatitis B carriage and hepatocellular carcinoma (HCC) incidence in Taiwan.
- Successful implementation of early HCC detection and prevention strategies.
- Pioneering the use of interferon-α plus ribavirin for chronic hepatitis C treatment.
Conclusions:
- Taiwan's 40-year experience in combating viral hepatitis offers valuable lessons for other endemic countries.
- Continued efforts are needed to address unresolved issues and adapt to evolving liver disease patterns.
- Public health strategies and antiviral therapies have dramatically impacted viral hepatitis outcomes.
Related Concept Videos
Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Yellow Fever
Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...
Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
